BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21623854)

  • 41. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant human growth hormone in short children born small for gestational age. German Study Group.
    Butenandt O; Lang G
    J Pediatr Endocrinol Metab; 1997; 10(3):275-82. PubMed ID: 9388818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does preterm birth influence the response to growth hormone treatment in short, small for gestational age children?
    de Kort SW; Willemsen RH; van der Kaay DC; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):582-7. PubMed ID: 19067725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-Mullerian hormone in short girls born small for gestational age and the effect of growth hormone treatment.
    Lem AJ; Boonstra VH; Renes JS; Breukhoven PE; de Jong FH; Laven JS; Hokken-Koelega AC
    Hum Reprod; 2011 Apr; 26(4):898-903. PubMed ID: 21227938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition.
    Schweizer R; Martin DD; Schönau E; Ranke MB
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2978-83. PubMed ID: 18505766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term.
    de Zegher F; Hokken-Koelega A
    Pediatrics; 2005 Apr; 115(4):e458-62. PubMed ID: 15805349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The exon 3 deleted growth hormone receptor gene is associated with small birth size and early pubertal onset in healthy boys.
    Sørensen K; Aksglaede L; Petersen JH; Leffers H; Juul A
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2819-26. PubMed ID: 20382688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of different growth hormone dosages on the growth velocity in children born small for gestational age.
    Bozzola E; Lauriola S; Messina MF; Bona G; Tinelli C; Tatò L
    Horm Res; 2004; 61(2):98-102. PubMed ID: 14654718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth Hormone (GH) receptor C.1319 G>T polymorphism, but not exon 3 retention or deletion is associated with better first-year growth response to GH therapy in patients with GH deficiency.
    Wan L; Chen WC; Tsai Y; Kao YT; Hsieh YY; Lee CC; Tsai CH; Chen CP; Tsai FJ
    Pediatr Res; 2007 Dec; 62(6):735-40. PubMed ID: 17957148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of the d3-growth hormone receptor polymorphism in large cohorts of small, appropriate and large for gestational age newborns.
    Vincenzi M; Ion Popa F; Corradi M; Gandini A; Teofoli F; Camilot M; Boner A; Cavarzere P; Gaudino R; Antoniazzi F
    Minerva Pediatr; 2016 Jun; 68(3):157-61. PubMed ID: 25411947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation of fl/d3 polymorphism of growth hormone receptor with the first- and second-year response to recombinant human growth hormone therapy in pre-pubertal Greek children with idiopathic isolated growth hormone deficiency.
    Vassiliou G; Rousso I; Katzos G; Vavatsi-Christaki N; Tzimagiorgis G
    J Endocrinol Invest; 2011 Sep; 34(8):609-14. PubMed ID: 20855935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency.
    Costalonga EF; Antonini SR; Guerra G; Coletta RR; Franca MM; Braz AF; Mendonca BB; Arnhold IJ; Jorge AA
    Pharmacogenomics J; 2012 Oct; 12(5):439-45. PubMed ID: 21468024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of first-year growth response to a fixed-dose growth hormone treatment in children born small for gestational age: results of an open-label, multicenter trial in the United States.
    Rapaport R; Saenger P; Wajnrajch MP;
    J Pediatr Endocrinol Metab; 2008 May; 21(5):411-22. PubMed ID: 18655522
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Final height in short children born small for gestational age treated with growth hormone.
    Dahlgren J; Wikland KA;
    Pediatr Res; 2005 Feb; 57(2):216-22. PubMed ID: 15585685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The PPAR-gamma Pro12Ala polymorphism associates with weight gain during GH-treatment in short children born small for gestational age.
    de Kort SW; Hokken-Koelega AC
    Eur J Endocrinol; 2010 Jan; 162(1):49-52. PubMed ID: 19808901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The interactive effect of GHR-exon 3 and -202 A/C IGFBP3 polymorphisms on rhGH responsiveness and treatment outcomes in patients with Turner syndrome.
    Braz AF; Costalonga EF; Montenegro LR; Trarbach EB; Antonini SR; Malaquias AC; Ramos ES; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E671-7. PubMed ID: 22278433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early differentiation between good and poor response to growth hormone therapy in short children born small for gestational age (SGA) to improve the outcome of poor responders.
    Jung H; Land C; Blum WF; Schöenau E
    J Pediatr Endocrinol Metab; 2014 Mar; 27(3-4):229-35. PubMed ID: 24150198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Common exon 3 polymorphism of the GH receptor (GHR) gene and effect of GH therapy on growth in Korean children with idiopathic short stature (ISS).
    Ko JM; Park JY; Yoo HW
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):82-7. PubMed ID: 18793346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A polymorphism in the growth hormone receptor is associated with height in children with Prader-Willi syndrome.
    Park SW; Lee ST; Sohn YB; Kim SH; Cho SY; Ko AR; Ji ST; Kwon JY; Yeau S; Paik KH; Kim JW; Jin DK
    Am J Med Genet A; 2011 Dec; 155A(12):2970-3. PubMed ID: 22052808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth hormone receptor sequence changes do not play a role in determining height in children with idiopathic short stature.
    Hujeirat Y; Hess O; Shalev S; Tenenbaum-Rakover Y
    Horm Res; 2006; 65(4):210-6. PubMed ID: 16582564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.